[{"address1": "Life Science & Technology Park", "address2": "Suite 520 1951 NW 7th Avenue", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "844 470 2550", "website": "https://longeveron.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 61, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 600622, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad M.B.A.", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1012339, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa A. Locklear M.B.A.", "age": 62, "title": "CFO, Executive VP & Treasurer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 653391, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 56, "title": "General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748514, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin  Blass", "age": 38, "title": "CTO & Senior VP of Chemistry, Manufacturing, and Controls", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nataliya  Agafonova M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  McClain-Moss", "age": 53, "title": "Vice President of Manufacturing", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian G Rash Ph.D.", "title": "VP of Research & Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heather  Zhou", "title": "VP & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.65, "open": 1.6439, "dayLow": 1.62, "dayHigh": 1.75, "regularMarketPreviousClose": 1.65, "regularMarketOpen": 1.6439, "regularMarketDayLow": 1.62, "regularMarketDayHigh": 1.75, "payoutRatio": 0.0, "beta": 0.363, "forwardPE": -1.1111112, "volume": 79890, "regularMarketVolume": 79890, "averageVolume": 313003, "averageVolume10days": 222160, "averageDailyVolume10Day": 222160, "bid": 1.7, "ask": 2.12, "bidSize": 1, "askSize": 2, "marketCap": 25377430, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 6.4, "priceToSalesTrailing12Months": 10.609294, "fiftyDayAverage": 1.616, "twoHundredDayAverage": 2.0355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6846040, "profitMargins": 0.0, "floatShares": 12621841, "sharesOutstanding": 13473900, "sharesShort": 559523, "sharesShortPriorMonth": 586064, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0375, "heldPercentInsiders": 0.10216, "heldPercentInstitutions": 0.08643, "shortRatio": 1.79, "shortPercentOfFloat": 0.044299997, "impliedSharesOutstanding": 14927900, "bookValue": 1.47, "priceToBook": 1.1564626, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -24623000, "trailingEps": -2.62, "forwardEps": -1.53, "lastSplitFactor": "1:10", "lastSplitDate": 1711497600, "enterpriseToRevenue": 2.862, "enterpriseToEbitda": -0.44, "52WeekChange": -0.5429363, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 1.7, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.875, "targetMedianPrice": 9.75, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 19232000, "totalCashPerShare": 1.288, "ebitda": -15564000, "totalDebt": 1447000, "quickRatio": 7.481, "currentRatio": 7.6, "totalRevenue": 2392000, "debtToEquity": 6.611, "revenuePerShare": 0.254, "returnOnAssets": -0.54874, "returnOnEquity": -1.1158999, "grossProfits": 1884000, "freeCashflow": -9274250, "operatingCashflow": -13868000, "revenueGrowth": 8.571, "grossMargins": 0.78763, "ebitdaMargins": 0.0, "operatingMargins": -7.0995, "financialCurrency": "USD", "symbol": "LGVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "corporateActions": [], "regularMarketTime": 1742412101, "exchange": "NCM", "messageBoardId": "finmb_410711455", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": 3.0303073, "regularMarketPrice": 1.7, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1613140200000, "regularMarketChange": 0.05000007, "regularMarketDayRange": "1.62 - 1.75", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 313003, "fiftyTwoWeekLowChange": 0.929, "fiftyTwoWeekLowChangePercent": 1.2049286, "fiftyTwoWeekRange": "0.771 - 6.4", "fiftyTwoWeekHighChange": -4.7, "fiftyTwoWeekHighChangePercent": -0.73437494, "fiftyTwoWeekChangePercent": -54.293633, "earningsTimestampStart": 1620989940, "earningsTimestampEnd": 1620989940, "epsTrailingTwelveMonths": -2.62, "epsForward": -1.53, "fiftyDayAverageChange": 0.08399999, "fiftyDayAverageChangePercent": 0.05198019, "twoHundredDayAverageChange": -0.3355, "twoHundredDayAverageChangePercent": -0.16482437, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-12", "prevName": "Longeveron LLC", "nameChangeDate": "2025-03-18", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Longeveron", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]